Compare ZVIA & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZVIA | LNSR |
|---|---|---|
| Founded | 2007 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Medical Electronics |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.3M | 106.6M |
| IPO Year | 2021 | 2005 |
| Metric | ZVIA | LNSR |
|---|---|---|
| Price | $1.27 | $6.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $4.93 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 354.9K | 61.5K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.88 | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | ★ $161,259,000.00 | $58,435,000.00 |
| Revenue This Year | $8.30 | $10.06 |
| Revenue Next Year | $6.87 | $41.48 |
| P/E Ratio | ★ N/A | $11.28 |
| Revenue Growth | 4.01 | ★ 9.24 |
| 52 Week Low | $1.11 | $4.95 |
| 52 Week High | $2.78 | $12.94 |
| Indicator | ZVIA | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 40.50 | 38.05 |
| Support Level | $1.26 | $5.17 |
| Resistance Level | $1.50 | $8.73 |
| Average True Range (ATR) | 0.07 | 0.32 |
| MACD | 0.00 | -0.15 |
| Stochastic Oscillator | 18.18 | 6.08 |
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.